Multidimensional analyses to assess the relations between treatment choices by physicians and patients’ characteristics: the example of COPD

• Main Authors: Roche Nicolas, Chouaid Christos, Delclaux Bertrand, Martinat Yan, Marcos Jean-Michel, Pégliasco Hervé, Scherrer Bruno
• Format: Article
• Language: English
• Published: BMC 2012-08-01
• Series: BMC Pulmonary Medicine
• Subjects: COPD; Factor analysis; Phenotype; Treatment; Management; Guidelines
• Online Access: http://www.biomedcentral.com/1471-2466/12/39

<p>Abstract</p> <p>Background</p> <p>In some situations, practice guidelines do not provide firm evidence-based guidance regarding COPD treatment choices, especially when large trials have failed to identify subgroups of particularly good or poor responders to available medications.</p> <p>Methods</p> <p>This observational cross-sectional study explored the yield of four types of multidimensional analyses to assess the associations between the clinical characteristics of COPD patients and pharmacological and non-pharmacological treatments prescribed by lung specialists in a real-life context.</p> <p>Results</p> <p>Altogether, 2494 patients were recruited by 515 respiratory physicians. Multiple correspondence analysis and hierarchical clustering identified 6 clinical subtypes and 6 treatment subgroups<it>.</it> Strong bi-directional associations were found between clinical subtypes and treatment subgroups in multivariate logistic regression. However, although the overall frequency of prescriptions varied from one clinical subtype to the other for all types of pharmacological treatments, clinical subtypes were not associated with specific prescription profiles. When canonical analysis of redundancy was used, the proportion of variation in pharmacological treatments that was explained by clinical characteristics remained modest: 6.23%. This proportion was greater (14.29%) for non-pharmacological components of care.</p> <p>Conclusion</p> <p>This study shows that, although pharmacological treatments of COPD are quantitatively very well related to patients’ clinical characteristics, there is no particular patient profile that could be qualitatively associated to prescriptions. This underlines uncertainties perceived by physicians for differentiating the respective effects of available pharmacological treatments. The methodology applied here is useful to identify areas of uncertainty requiring further research and/or guideline clarification.</p>